Patient‐reported outcomes as non‐muscle‐invasive bladder cancer clinical trial endpoints
Kimberly Toumazos,
Spencer Bell,
Katelyn Spencer,
Darrell Nakagawa,
Kelly K. Bree,
Ashish M. Kamat,
Sarah P. Psutka,
Patrick J. Hensley BJU International
· Wiley
· 2026-11-06
· DOI: 10.1111/bju.70461
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Kimberly Toumazos, Spencer Bell, Katelyn Spencer, Darrell Nakagawa, Kelly K. Bree, Ashish M. Kamat et al. Patient‐reported outcomes as non‐muscle‐invasive bladder cancer clinical trial endpoints. // BJU International. – 2026. – DOI: 10.1111/bju.70461. – URL: https://bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bju.70461?af=R
Kimberly Toumazos, Spencer Bell, Katelyn Spencer, Darrell Nakagawa, Kelly K. Bree, Ashish M. Kamat, Sarah P. Psutka, & Patrick J. Hensley (2026). Patient‐reported outcomes as non‐muscle‐invasive bladder cancer clinical trial endpoints. BJU International. https://doi.org/10.1111/bju.70461
Kimberly Toumazos, et al. “Patient‐reported outcomes as non‐muscle‐invasive bladder cancer clinical trial endpoints.” BJU International, 2026. doi:10.1111/bju.70461.
@article{Toumazos2026,
title = {Patient‐reported outcomes as non‐muscle‐invasive bladder cancer clinical trial endpoints},
author = {Toumazos, Kimberly and Bell, Spencer and Spencer, Katelyn and Nakagawa, Darrell and Bree, Kelly K. and Kamat, Ashish M. and Psutka, Sarah P. and Hensley, Patrick J.},
journal = {BJU International},
year = {2026},
doi = {10.1111/bju.70461},
url = {https://bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bju.70461?af=R}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...